Introduction {#sec1}
============

Trehalose (α-D-glucopyranosyl-(1→1)-α-D-glucopyranoside) is a nonreducing disaccharide that has many roles in biology ([@bib1]; [@bib11]; [@bib24]). For example, it is a precursor for cell wall trehalose mycolates ([Figure 1](#fig1){ref-type="fig"}A) that are essential for the growth and virulence of mycobacteria, such as *Mycobacterium tuberculosis* ([@bib32]), the causative agent of the globally widespread human disease tuberculosis ([@bib10]). For this reason, trehalose has attracted attention in the development of imaging agents ([@bib3]; [@bib30]) and drugs ([@bib18]; [@bib25]; [@bib37]) to help diagnose and treat tuberculosis. It has been widely thought that there are three pathways responsible for the biosynthesis of trehalose in mycobacteria ([Figure 1](#fig1){ref-type="fig"}A): the OtsAB, TreYZ, and trehalose synthase (TreS) pathways ([@bib2]; [@bib11]). In vitro experiments have shown that all three pathways could, in principle, operate in mycobacteria ([@bib8]). In addition, genetic experiments appeared to show that all pathways are capable of synthesizing trehalose de novo in the fast-growing avirulent species *Mycobacterium smegmatis* ([@bib40]). By contrast, it has been reported that the OtsAB pathway is dominant in trehalose biosynthesis in *Mycobacterium tuberculosis* and that TreS could have a role only in late-stage pathogenesis in infected mice ([@bib20]). This implies *Mycobacterium smegmatis* is not an appropriate model organism with respect to the metabolism of trehalose in *Mycobacterium tuberculosis*. The picture is complicated further by evidence that only the OtsAB and TreYZ pathways, but not the TreS pathway, appear to be important in the de novo biosynthesis of trehalose and trehalose mycolate formation in the related actinomycete, *Corynebacterium glutamicum* ([@bib36]; [@bib39]).

TreS is a maltose α-D-glucosylmutase (EC 5.4.99.16) that interconverts maltose (α-D-glucopyranosyl-(1,4)-D-glucopyranose) and trehalose ([@bib21]; [@bib23]). Therefore, an oft ignored puzzle has been the lack of an obvious and significant source of maltose in a mycobacterium either from its own metabolism or its environment. This is compounded by the lack of a maltose transporter in *Mycobacterium tuberculosis* ([@bib15]). However, we recently discovered an alternative route for α-glucan biosynthesis, the GlgE pathway, which is widespread among bacteria and involves the consumption of trehalose by TreS ([@bib7]; [@bib16]). These observations prompt the question as to whether TreS contributes to the biosynthesis of either trehalose mycolate, α-glucans, or both in mycobacteria.

There are no reports of experimental evidence defining the anomeric configuration of maltose that TreS produces. The configuration could have consequences for metabolic flux, because the nonenzymatic mutarotation of maltose is so slow that the half-life of anomeric equilibration is of the order of tens of minutes ([@bib4]). Furthermore, although maltose mutarotase enzymes are known, they appear to be rare and have only been detected in higher plants ([@bib4]) and *Lactobacillus brevis* ([@bib27]). TreS is a glycoside hydrolase GH13_3 ([@bib28]) family member according to the CaZy database ([@bib5]). Thus, it is predicted to have a (β/α)~8~ fold, defining an active site containing an Asp nucleophile and a Glu proton donor that catalyze an α-retaining double-displacement reaction mechanism ([Figure 1](#fig1){ref-type="fig"}B). In support of this mechanism, evidence for the glucosyl-enzyme intermediate involving Asp230 in the *Mycobacterium smegmatis* enzyme has been reported recently ([@bib41]). One would therefore predict that α-maltose is utilized and produced by TreS, but evidence to support this notion is currently lacking.

We now show, using a genetic approach, that flux through TreS is from rather than to trehalose in both *Mycobacterium smegmatis* and *Mycobacterium tuberculosis*. Therefore, TreS supplies intermediates for the GlgE α-glucan pathway rather than the trehalose mycolate pathway, both potential targets for imaging agents and therapeutic inhibitors. Furthermore, we show using ^1^H-nuclear magnetic resonance (NMR) spectroscopy, supported by ^19^F-NMR spectroscopy and deoxyfluoro substrate analogs, that the appropriate α anomer of maltose is formed for maltose kinase of the GlgE pathway. These findings have implications for the study and targeting of trehalose-dependent pathways in mycobacteria and other bacteria.

Results {#sec2}
=======

Characterization of Trehalose Auxotrophs of *Mycobacterium Smegmatis* {#sec2.1}
---------------------------------------------------------------------

In order to definitively assess the contribution of TreS for the de novo biosynthesis of essential trehalose in mycobacteria, we generated site-specific gene deletion mutants in *Mycobacterium smegmatis* in the three reported trehalose biosynthetic pathways by targeting the genes *treS*, *otsA*, and *treY1*-*treY2*-*treZ,* both individually and in combination ([Figure S1](#app2){ref-type="sec"} available online). Inactivation of *treS* alone or in combination with either *otsA* or *treYZ* did not lead to any detectable growth defect in the absence of exogenous trehalose ([Figure 2](#fig2){ref-type="fig"}A). In contrast, we found that not only the Δ*treS*(u)Δ*otsA*(u)Δ*treYZ* triple mutant but also the Δ*otsA*(u)Δ*treYZ* double mutant strictly required trehalose supplementation for growth on solid medium ([Figure 2](#fig2){ref-type="fig"}B) and in liquid culture ([Figure 2](#fig2){ref-type="fig"}C), despite the double mutant possessing an intact *treS* gene. Supplementation with exogenous trehalose in the μM range was sufficient to support growth of these two trehalose auxotrophs ([Figure 2](#fig2){ref-type="fig"}C), showing that TreS does not contribute significantly to the de novo production of trehalose in *Mycobacterium smegmatis*. In the absence of trehalose, exogenous maltose in the mM range could partially restore growth of the Δ*otsA*(u)Δ*treYZ* but not the Δ*treS*(u)Δ*otsA*(u)Δ*treYZ* mutant ([Figure 2](#fig2){ref-type="fig"}D). These data indicate that TreS could be capable of synthesizing trehalose in mycobacteria but that the biosynthesis of maltose is severely limited in the growth conditions tested.

TreS Consumes Trehalose in *Mycobacterium Tuberculosis* {#sec2.2}
-------------------------------------------------------

In order to assess the direction of flux through TreS in *Mycobacterium tuberculosis*, we analyzed intracellular trehalose levels in *Mycobacterium tuberculosis* wild-type, the Δ*treS* mutant and *treS*-overexpressing strains ([Figure 2](#fig2){ref-type="fig"}E). Deletion of *treS* had no influence on the intracellular trehalose concentration, precluding the ability to distinguish between TreS having a role in trehalose formation and consumption. However, the intracellular trehalose level in the *treS*-overexpressing strain was dramatically reduced, which indicates that TreS has a role in the consumption of trehalose in *Mycobacterium tuberculosis*, a direction of flux consistent with that in *Mycobacterium smegmatis*.

TreS Interconverts Trehalose with the α Anomer of Maltose According to ^1^H-NMR Spectroscopy {#sec2.3}
--------------------------------------------------------------------------------------------

With a view to establishing whether TreS interconverts the α anomer of maltose, we explored the use of ^1^H-NMR spectroscopy. A spectrum of a reaction mixture generated from maltose by TreS allowed each component to be detected ([Figure S2](#app2){ref-type="sec"}A), including glucose, a known product of hydrolysis ([@bib22]; [@bib23]; [@bib41]), and the anomers of each reducing sugar. Since anomers mutarotate nonenzymatically, their equilibration upon dissolution of crystalline materials in citrate buffer at 25°C was monitored using ^1^H-NMR spectroscopy ([Figure S2](#app2){ref-type="sec"}B). The rate constants determined for the mutarotation of α-glucose to β-glucose and the reverse reaction were 0.0316 ± 0.0004 and 0.0192 ± 0.0004 min^−1^ and, for maltose, 0.0286 ± 0.0002 and 0.0187 ± 0.0001 min^−1^, each respectively ([Figure S2](#app2){ref-type="sec"}C). These rate constants were consistent with the literature ([@bib4]; [@bib29]) and the expected dominance of the β anomers.

The conversion of trehalose into maltose by TreS in citrate buffer as a function of time was monitored using ^1^H-NMR spectroscopy ([Figure 3](#fig3){ref-type="fig"}A). The α anomer of maltose was formed 5.4-fold more rapidly than its β anomer, suggesting TreS generates the α anomer. A low level of glucose was also produced through hydrolysis, as observed previously. At longer times, the ratio between trehalose and α/β-maltose was 2.2:1 (at 25°C and pH 6.7), which is reasonably similar to the equilibrium position of 4.6:1 determined from the free energies of hydrolysis of these disaccharides (at 25°C and pH 5.65) ([@bib31]; [@bib34]; [@bib35]) and of 3.2:1 determined from the kinetics of *Mycobacterium smegmatis* TreS ([@bib41]). The expected equilibrium positions between the anomers of both maltose and glucose were also approached at longer times.

As TreS formed trehalose from pre-equilibrated α/β-maltose (α:β anomeric ratio of 1:1.5), a rapid depletion of α-maltose was immediately apparent ([Figure 3](#fig3){ref-type="fig"}B). By contrast, the consumption of β-maltose was significantly slower and conformed to a single exponential function ([Figure S2](#app2){ref-type="sec"}D) with a rate of 0.019 min^−1^ that was consistent with the rate constant for the mutarotation described above (0.0187 ± 0.0001 min^−1^). This implied that TreS does not utilize the β anomer. When the experiment was repeated with lower TreS concentrations, the rate of consumption of α-maltose decreased, while that of the β anomer remained similar. Thus, the transient increase in the β/α ratio of the maltose anomers was less pronounced at lower enzyme concentrations ([Figure 3](#fig3){ref-type="fig"}C), providing further evidence that TreS converts only the α anomer of maltose into trehalose, as expected. While the initial formation of glucose through hydrolysis appeared to be more rapid from maltose than trehalose, this most likely reflected the more rapid initial consumption of maltose. This implies the equal probability of either α-maltose or trehalose being hydrolyzed. It is also noteworthy that the α anomer of glucose was produced more rapidly from maltose than its β anomer, suggesting that α-glucose is the product of hydrolysis.

The Specificity of TreS for the α Anomer of Maltose Is Retained with Deoxyfluoro Analogs According to ^19^F-NMR Spectroscopy {#sec2.4}
----------------------------------------------------------------------------------------------------------------------------

Deoxyfluorotrehalose analogs have been shown to label *Mycobacterium tuberculosis* cells and exhibit weak antimycobacterial activity ([@bib3]). Since *Mycobacterium tuberculosis* has a trehalose transporter ([@bib15]) and TreS has been reported to utilize 2-fluoro-2-deoxymaltose as a substrate ([@bib41]), the ability of TreS to convert 2-, 3-, and 6-deoxyfluoromaltose analogs ([@bib33]) was monitored using ^19^F-NMR spectroscopy ([Figure 4](#fig4){ref-type="fig"}). The 2-deoxy-2-fluoro and 6-deoxy-6-fluoro compounds were converted to the corresponding deoxyfluorotrehalose analogs ∼2-fold and ∼180-fold less efficiently than the normal substrate ([Figures 4](#fig4){ref-type="fig"}A and 4C). The hydrolysis of each analog to the corresponding deoxyfluoroglucose compounds was detected ([Figures 4](#fig4){ref-type="fig"}A--4C), particularly with the 3-fluoro-3-deoxy and 6-fluoro-6-deoxy compounds, with the former being exclusively hydrolyzed ([Figure 4](#fig4){ref-type="fig"}B). The expected concomitant formation of nonfluorinated glucose was detected using ^1^H-NMR spectroscopy (data not shown). The α anomer was consumed more rapidly than the β anomer with all three analogs ([Figures 4](#fig4){ref-type="fig"}A--4C), consistent with TreS only acting on α anomers. The mutarotation rates of the deoxyfluoro analogs are not known, but fitting the decay of the β anomer of the 2-deoxy-2-fluoro analog ([Figure 4](#fig4){ref-type="fig"}A) suggested a rate constant of ∼0.004 min^−1^, an order of magnitude slower than that for maltose.

In order to assess whether fluoro substitution at the three and six positions resulted in poor binding to TreS or slow conversion by TreS, the extent of conversion of 0.52 mM 2-deoxy-2-fluoromaltose was monitored in the presence and absence of 2.1 mM of each of the other two analogs ([Figure S3](#app2){ref-type="sec"}D). Neither of the analogs gave inhibition, and there may indeed have been a modest stimulation of activity. Given that the *K*~m~ for maltose is 8--10 mM with the *Mycobacterium smegmatis* enzyme ([@bib23]; [@bib41]) and the *K*~m~ for the 2-deoxy-2-fluoro analog would not be expected to be orders of magnitude lower than this, the lack of inhibition is consistent with fluoro substitution at the three and six positions, compromising the ability of maltose analogs to bind to TreS.

Discussion {#sec3}
==========

We have shown that the direction of flux through TreS is from trehalose to maltose and that the source of trehalose is a combination of the OtsAB and TreYZ pathways in *Mycobacterium smegmatis* ([Figure 2](#fig2){ref-type="fig"}). The overexpression of TreS led to a decrease in trehalose levels, indicating the same direction of flux in *Mycobacterium tuberculosis*. Thus, TreS appears not to generate trehalose for trehalose mycolate biosynthesis but to convert trehalose into maltose for the GlgE pathway in mycobacteria ([@bib12]; [@bib16]). Although the equilibrium of the TreS-catalyzed reaction is not in line with the direction of flux, the ATP requirement of maltose kinase for the formation of α-maltose 1-phosphate provides most of the driving force through the GlgE pathway, as discussed elsewhere ([@bib31]). Consistent with this, exogenously supplied ^14^C-labeled trehalose is rapidly and substantially converted to α-maltose 1-phosphate in a *Mycobacterium smegmatis* Δ*glgE* mutant, with maltose only being detected when the *pep2* maltose kinase gene was inactivated ([@bib16]). The observed direction of flux contrasts with a previous study in *Mycobacterium smegmatis* ([@bib40]). However, the authors did not employ a defined Δ*otsA*Δ*treY* double mutant to study the specific contribution of TreS in the de novo biosynthesis of trehalose but rather a surrogate strain (a Δ*otsA*Δ*treS*Δ*treY* triple mutant with a reconstituted *treS* gene constitutively expressed from an episomal multicopy plasmid) that likely exhibited a much higher *treS* expression level compared with the native gene. Moreover, as nonspecified culture conditions were used, it is unclear whether the medium was devoid of maltose, which might be sufficient to support growth in this genetic context in the absence of trehalose. In any case, our observations are consistent with those of others in *Mycobacterium tuberculosis* ([@bib20]) and *Corynebacterium glutamicum* ([@bib36]; [@bib39]). Thus, we have shown that the metabolism of trehalose in *Mycobacterium smegmatis* is similar to that in *Mycobacterium tuberculosis* after all, allowing *Mycobacterium smegmatis* to be used as a model organism in this context. Furthermore, our *Mycobacterium smegmatis* strains, particularly the strains that are auxotrophic for trehalose, could be used to study the impact of trehalose analogs on specific pathways. It is also intriguing that TreS may be important in late-stage pathogenesis in mice ([@bib20]), implying a potential role of GlgE pathway-generated cytosolic and/or capsular α-glucan in this process, noting that the latter has been implicated in immune evasion ([@bib26]).

TreS generates the appropriate α anomer for maltose kinase ([@bib9]; [@bib19]) of the GlgE pathway ([@bib16]). Thus, the formation of α-maltose 1-phosphate is not limited by the mutarotation of maltose in mycobacteria. This is relevant to many other species, because the *treS* gene coexists with the other genes of the GlgE pathway in 14% of all sequenced bacterial genomes ([@bib7]). In a further 28% of genomes that possess the *treS* gene, one or more of the other GlgE pathway genes is missing. It is therefore not possible to rule out that flux through TreS favors the conversion of maltose to trehalose in organisms that have access to sufficient cytosolic maltose from intracellular or extracellular sources. If the maltose were generated by an enzyme such as β-amylase, the mutarotation of β-maltose could become an issue for flux through TreS to trehalose. Indeed, this work highlights that the mutarotation of any given reducing sugar should not be assumed to be fast compared with the metabolism of a specific sugar anomer.

It is now possible to propose schemes defining the anomeric configurations and origins of all species associated with the TreS-catalyzed reactions studied ([Figures 3](#fig3){ref-type="fig"}D and [4](#fig4){ref-type="fig"}D). TreS interconverts the α anomer of maltose ([Figures 3](#fig3){ref-type="fig"}A--3C) as expected ([Figure 1](#fig1){ref-type="fig"}B), and specificity was also retained with deoxyfluoro analogs ([Figures 4](#fig4){ref-type="fig"}A--4C). The TreS enzyme is thought to sterically capture the glucose molecule that it liberates ([Figure 1](#fig1){ref-type="fig"}B) and transiently exclude access to the active site such that exogenously supplied glucose does not get incorporated into the products of TreS ([@bib17]; [@bib22]; [@bib41]). Thus, TreS catalyzes an isomerization, whereby the noncovalently captured glucose molecule must rotate within an enclosed active site. We have now established that this glucose molecule retains its α configuration, whether it goes on to produce normal disaccharide products or is released in the hydrolytic side reaction. Therefore, TreS catalyzes the mutarotation of neither maltose nor glucose.

Unlike trehalose, the deoxyfluorotrehalose products are asymmetric and might have been converted to the corresponding n′-deoxy-n′-fluoromaltose analogs but were not ([Figure 4](#fig4){ref-type="fig"}D). This could have been due to the destabilization of oxocarbenium ion-like transition states associated with these reactions ([@bib38]). Alternatively, other effects could be involved, such as reduced binding affinities. Indeed, neither of the 3-deoxy-3-fluoro and 6-deoxy-6-fluoromaltose analogs appeared to bind well to the enzyme. That 3-deoxy-3-fluoromaltose was exclusively hydrolyzed means that 3-deoxy-3-fluoroglucose is less able than a water molecule to attack the glucosyl-enzyme intermediate. This could be due to changes in the nucleophilicity of 3-deoxy-3-fluoroglucose or more likely to an inability to orient itself appropriately within the active site.

Significance {#sec4}
============

**Our findings about the flux through TreS to supply the trehalose mycolate and α-glucan biosynthetic pathways (**[Figure 1](#fig1){ref-type="fig"}**A) have implications for the design and efficacy of inhibitors/imaging agents that target them (**[@bib3]**;** [@bib30]**). It is now much clearer which enzymes need to be targeted to affect either one or both of these pathways. Furthermore, substrate analogs can now be designed as prodrugs for a given pathway that avoid detoxification by competing pathways. For example, when targeting the synthesis of essential trehalose mycolates (**[@bib3]**;** [@bib30]**), it would be an advantage if trehalose analogs were not converted and deactivated by TreS. Indeed, we have observed the limited ability of TreS to tolerate relatively small modifications of its substrates. However, when targeting GlgE or GlgB (**[@bib14]**), there is the challenge of a trehalose analog being tolerated by not only TreS but also the trehalose importer (**[@bib15]**) and maltose kinase. Therefore, the weak inhibition of the growth of *Mycobacterium tuberculosis* by either 2-deoxy-2-fluoro or 6-deoxy-6-fluoromaltose (**[@bib3]**) could be due to a lack of either import, efficient processing, and/or inhibition of the GlgE/GlgB targets. Interestingly, labeling of *Mycobacterium smegmatis* using a 4-azido analog of trehalose is TreS-dependent (**[@bib30]**). This observation implies the tolerance of this analog through each step in the biosynthesis of capsular α-glucan rather than trehalose mycolates. Our work supports this interpretation and also shows that this observation in *Mycobacterium smegmatis* is likely to be relevant to *Mycobacterium tuberculosis*.**

Experimental Procedures {#sec5}
=======================

All details about the Experimental Procedures used are given in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Supplemental Information {#app2}
========================
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![Metabolism of Trehalose in Mycobacteria and Proposed Mechanism of TreS\
(A) All known metabolic pathways associated with trehalose in mycobacteria are shown, except for its hydrolysis by trehalase to form glucose as a carbon source for growth ([@bib6]). The questions addressed by this work are indicated in boxes.\
(B) Proposed catalytic mechanism of TreS with the most likely relative orientations of the glucose rings of trehalose and maltose. Hydrolysis would be expected to occur when water attacks the glucosyl-enzyme intermediate, generating a second glucose molecule with an α anomeric configuration.](gr1){#fig1}

![The TreS Pathway Does Not Contribute to the De Novo Biosynthesis of Trehalose in Mycobacteria\
(A) Trehalose growth requirements in liquid culture of *Mycobacterium smegmatis* gene deletion mutants (see [Figure S1](#app2){ref-type="sec"} for how they were generated). Cultures were incubated for 48 hr at 37°C in Middlebrook 7H9 medium containing 0.5% (v/v) glycerol and 10% (v/v) albumin-dextrose-saline (ADS) enrichment containing either 0 or 50 μM trehalose. Values are means of triplicates ± SD.\
(B) Trehalose growth requirements on solid media of the trehalose-auxotrophic *Mycobacterium smegmatis* mutants Δ*otsA*(u)Δt*reYZ* and Δ*treS*(u)Δ*otsA*(u)Δ*treYZ*. Cells were cultivated for 72 hr on Middlebrook 7H10 agar containing 0.5% (v/v) glycerol and 10% (v/v) ADS enrichment in the presence or absence of 100 μM trehalose.\
(C) Trehalose growth requirements in liquid culture of the trehalose-auxotrophic *Mycobacterium smegmatis* mutants Δ*otsA*(u)Δ*treYZ* and Δ*treS*(u)Δ*otsA*(u)Δ*treYZ*. Growth conditions were essentially as described for (A) with 0--50 μM trehalose.\
(D) Maltose supplementation of trehalose auxotrophic *Mycobacterium smegmatis* gene deletion mutants. Growth conditions were essentially as described for (A) without trehalose but with 0--10 mM maltose. Values are means of triplicates ± SD.\
(E) Effect of *treS* deficiency and overexpression on intracellular trehalose concentration in *Mycobacterium tuberculosis*. Cultures of *Mycobacterium tuberculosis* H37Rv wild-type, the Δ*treS* mutant and a *treS* overexpressing strain (wild type \[WT\] + *treS*) were incubated for 14 days in Middlebrook 7H9 medium containing 0.5% (v/v) glycerol and 10% (v/v) oleic acid-albumin-dextrose-catalase enrichment before enzymatically determining trehalose concentrations. Values are means of sextuplicates ± SD.](gr2){#fig2}

![*Mycobacterium Tuberculosis* TreS Interconverts the α Anomer of Maltose\
(A) The conversion of trehalose (10 mM) into maltose by TreS (2 μM) according to ^1^H-NMR spectroscopy (see [Figures S2](#app2){ref-type="sec"}A--S2C for representative spectra and nonenzymic mutarotation controls). Each component was quantified by signal integration using citrate as an internal standard. Reaction mixtures contained 10% D~2~O to assist spectrum acquisition without significant risk of introducing solvent kinetic and/or equilibrium isotope effects. This necessitated solvent suppression and the introduction of experimentally determined correction factors for the cosuppression of resonances that were close to the solvent resonance.\
(B) The conversion of pre-equilibrated α/β-maltose (10 mM) into trehalose by TreS (2 μM) according to ^1^H-NMR spectroscopy. Note that enzyme was added immediately after the t = 0 data were acquired, resulting in a small and reproducible change in the apparent concentration of starting materials at the second recorded time point. See [Figure S2](#app2){ref-type="sec"}D for the fit of the β-maltose curve ([@bib13]). The times taken to produce 2 mM trehalose and consume 50% of the α/β-maltose were 14 and 55 min, respectively.\
(C) Time courses of the ratios between the β and α anomers of maltose with different TreS concentrations during the conversion of pre-equilibrated α/β-maltose. The broken line indicates the equilibrium between the two anomers in these conditions.\
(D) Proposed reaction scheme to account for TreS-catalyzed reactions. Protons used to quantify components of the reaction mixtures by ^1^H-NMR spectroscopy ([Figure S2](#app2){ref-type="sec"}A) are indicated.](gr3){#fig3}

![*Mycobacterium Tuberculosis* TreS Converts the α Anomers of Deoxyfluoromaltose Analogs\
(A) The conversion of pre-equilibrated 2-deoxy-2-fluoro-α/β-maltose (10 mM) by TreS (2 μM) was monitored using ^19^F-NMR spectroscopy (see [Figure S3](#app2){ref-type="sec"}A for spectra). The times taken to produce 2 mM 2-deoxy-2-fluorotrehalose and consume 50% of the maltose analog were 25 and 125 min, respectively, both ∼2-fold longer than with maltose.\
(B) Corresponding data with 3-deoxy-3-fluoro-α/β-maltose ([Figure S3](#app2){ref-type="sec"}B). The time taken to consume 50% of the maltose analog was 1,100 min, 20-fold longer than with maltose. No 3-deoxy-3-fluorotrehalose was detected.\
(C) Corresponding data with 6-deoxy-6-fluoro-α/β-maltose ([Figure S3](#app2){ref-type="sec"}C). The times taken to produce 2 mM 6-deoxy-6-fluorotrehalose and consume 50% of the maltose analog were 2,500 and 1,500 min, respectively, 180- and 27-fold longer than with maltose.\
(D) Proposed reaction scheme to account for the conversion of deoxyfluoromaltoses by TreS.](gr4){#fig4}
